Neurological Biomarkers Market Report

Europe Neurological Biomarkers Market Size, Status and Forecast 2014-2026

  • POSTDATE：Jun 21, 2020
  • PAGES：202
  • REPORT CODE：GMM575761
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Neurological Biomarkers market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 2.7% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe Neurological Biomarkers Market Segmentations:

    By Player:

    • Merck

    • Genewiz

    • Proteome Sciences

    • Cisbio Bioassays

    • Aepodia

    • QIAGEN

    • Wuxi APP

    • Athena Diagnostics

    • Myriad RBM

    • BGI

    • Roche

    • Bio-Rad Laboratories

    • Thermo Fisher

    By Type:

    • Proteomics

    • Genomics

    • Imaging

    • Bioinformatics

    • Others

    By End-User:

    • Diagnostics

    • Drug Discovery

    • Personalized Medicine

    • Others

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Neurological Biomarkers Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe Neurological Biomarkers Market Size and Growth Rate of Proteomics from 2014 to 2026

    • 1.3.2 Europe Neurological Biomarkers Market Size and Growth Rate of Genomics from 2014 to 2026

    • 1.3.3 Europe Neurological Biomarkers Market Size and Growth Rate of Imaging from 2014 to 2026

    • 1.3.4 Europe Neurological Biomarkers Market Size and Growth Rate of Bioinformatics from 2014 to 2026

    • 1.3.5 Europe Neurological Biomarkers Market Size and Growth Rate of Others from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe Neurological Biomarkers Market Size and Growth Rate of Diagnostics from 2014 to 2026

    • 1.4.2 Europe Neurological Biomarkers Market Size and Growth Rate of Drug Discovery from 2014 to 2026

    • 1.4.3 Europe Neurological Biomarkers Market Size and Growth Rate of Personalized Medicine from 2014 to 2026

    • 1.4.4 Europe Neurological Biomarkers Market Size and Growth Rate of Others from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany Neurological Biomarkers Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK Neurological Biomarkers Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France Neurological Biomarkers Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy Neurological Biomarkers Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain Neurological Biomarkers Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland Neurological Biomarkers Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia Neurological Biomarkers Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland Neurological Biomarkers Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey Neurological Biomarkers Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Neurological Biomarkers Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) Neurological Biomarkers Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) Neurological Biomarkers Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Neurological Biomarkers Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Neurological Biomarkers by Major Types

      • 3.4.1 Market Size and Growth Rate of Proteomics

      • 3.4.2 Market Size and Growth Rate of Genomics

      • 3.4.3 Market Size and Growth Rate of Imaging

      • 3.4.4 Market Size and Growth Rate of Bioinformatics

      • 3.4.5 Market Size and Growth Rate of Others

    4 Segmentation of Neurological Biomarkers Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Neurological Biomarkers by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Diagnostics for Construction

      • 4.4.2 Market Size and Growth Rate of Drug Discovery for Construction

      • 4.4.3 Market Size and Growth Rate of Personalized Medicine for Construction

      • 4.4.4 Market Size and Growth Rate of Others for Construction

    5 Market Analysis by Major Regions

    • 5.1 Europe Neurological Biomarkers Production Analysis by Top Regions

    • 5.2 Europe Neurological Biomarkers Consumption Analysis by Top Regions

    • 5.3 Europe Neurological Biomarkers Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany Neurological Biomarkers Production, Import, Consumption and Export Analysis

      • 5.3.2 UK Neurological Biomarkers Production, Import, Consumption and Export Analysis

      • 5.3.3 France Neurological Biomarkers Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy Neurological Biomarkers Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain Neurological Biomarkers Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland Neurological Biomarkers Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia Neurological Biomarkers Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland Neurological Biomarkers Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey Neurological Biomarkers Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Neurological Biomarkers Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) Neurological Biomarkers Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) Neurological Biomarkers Production, Import, Consumption and Export Analysis

    6 Product Circulation of Neurological Biomarkers Market among Top Countries

    • 6.1 Top 5 Export Countries in Neurological Biomarkers Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Neurological Biomarkers Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Neurological Biomarkers Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Neurological Biomarkers Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Neurological Biomarkers Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Neurological Biomarkers Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany Neurological Biomarkers Landscape Analysis

    • 7.1 Germany Neurological Biomarkers Landscape Analysis by Major Types

    • 7.2 Germany Neurological Biomarkers Landscape Analysis by Major End-Users

    8. UK Neurological Biomarkers Landscape Analysis

    • 8.1 UK Neurological Biomarkers Landscape Analysis by Major Types

    • 8.2 UK Neurological Biomarkers Landscape Analysis by Major End-Users

    9. France Neurological Biomarkers Landscape Analysis

    • 9.1 France Neurological Biomarkers Landscape Analysis by Major Types

    • 9.2 France Neurological Biomarkers Landscape Analysis by Major End-Users

    10. Italy Neurological Biomarkers Landscape Analysis

    • 10.1 Italy Neurological Biomarkers Landscape Analysis by Major Types

    • 10.2 Italy Neurological Biomarkers Landscape Analysis by Major End-Users

    11. Spain Neurological Biomarkers Landscape Analysis

    • 11.1 Spain Neurological Biomarkers Landscape Analysis by Major Types

    • 11.2 Spain Neurological Biomarkers Landscape Analysis by Major End-Users

    12. Poland Neurological Biomarkers Landscape Analysis

    • 12.1 Poland Neurological Biomarkers Landscape Analysis by Major Types

    • 12.2 Poland Neurological Biomarkers Landscape Analysis by Major End-Users

    13. Russia Neurological Biomarkers Landscape Analysis

    • 13.1 Russia Neurological Biomarkers Landscape Analysis by Major Types

    • 13.2 Russia Neurological Biomarkers Landscape Analysis by Major End-Users

    14. Switzerland Neurological Biomarkers Landscape Analysis

    • 14.1 Switzerland Neurological Biomarkers Landscape Analysis by Major Types

    • 14.2 Switzerland Neurological Biomarkers Landscape Analysis by Major End-Users

    15. Turkey Neurological Biomarkers Landscape Analysis

    • 15.1 Turkey Neurological Biomarkers Landscape Analysis by Major Types

    • 15.2 Turkey Neurological Biomarkers Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Neurological Biomarkers Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Neurological Biomarkers Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Neurological Biomarkers Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Neurological Biomarkers Landscape Analysis by Top Countries

      • 16.3.1 Denmark Neurological Biomarkers Market Volume and Growth Rate

      • 16.3.2 Finland Neurological Biomarkers Market Volume and Growth Rate

      • 16.3.3 Norway Neurological Biomarkers Market Volume and Growth Rate

      • 16.3.4 Sweden Neurological Biomarkers Market Volume and Growth Rate

      • 16.3.6 Iceland Neurological Biomarkers Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) Neurological Biomarkers Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) Neurological Biomarkers Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) Neurological Biomarkers Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) Neurological Biomarkers Landscape Analysis by Top Countries

      • 17.3.1 Belgium Neurological Biomarkers Market Volume and Growth Rate

      • 17.3.2 Netherlands Neurological Biomarkers Market Volume and Growth Rate

      • 17.3.3 Luxembourg Neurological Biomarkers Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) Neurological Biomarkers Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) Neurological Biomarkers Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) Neurological Biomarkers Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) Neurological Biomarkers Landscape Analysis by Top Countries

      • 18.3.1 Estonia Neurological Biomarkers Market Volume and Growth Rate

      • 18.3.2 Latvia Neurological Biomarkers Market Volume and Growth Rate

      • 18.3.3 Lithuania Neurological Biomarkers Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 Merck

      • 19.1.1 Merck Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 Genewiz

      • 19.2.1 Genewiz Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 Proteome Sciences

      • 19.3.1 Proteome Sciences Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 Cisbio Bioassays

      • 19.4.1 Cisbio Bioassays Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 Aepodia

      • 19.5.1 Aepodia Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 QIAGEN

      • 19.6.1 QIAGEN Company Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    • 19.7 Wuxi APP

      • 19.7.1 Wuxi APP Company Profile and Development Status

      • 19.7.2 Market Performance

      • 19.7.3 Product and Service Introduction

    • 19.8 Athena Diagnostics

      • 19.8.1 Athena Diagnostics Company Profile and Development Status

      • 19.8.2 Market Performance

      • 19.8.3 Product and Service Introduction

    • 19.9 Myriad RBM

      • 19.9.1 Myriad RBM Company Profile and Development Status

      • 19.9.2 Market Performance

      • 19.9.3 Product and Service Introduction

    • 19.10 BGI

      • 19.10.1 BGI Company Profile and Development Status

      • 19.10.2 Market Performance

      • 19.10.3 Product and Service Introduction

    • 19.11 Roche

      • 19.11.1 Roche Company Profile and Development Status

      • 19.11.2 Market Performance

      • 19.11.3 Product and Service Introduction

    • 19.12 Bio-Rad Laboratories

      • 19.12.1 Bio-Rad Laboratories Company Profile and Development Status

      • 19.12.2 Market Performance

      • 19.12.3 Product and Service Introduction

    • 19.13 Thermo Fisher

      • 19.13.1 Thermo Fisher Company Profile and Development Status

      • 19.13.2 Market Performance

      • 19.13.3 Product and Service Introduction

    The List of Tables and Figures (Totals 81 Figures and 186 Tables)

    • Figure Product Picture

    • Figure Neurological Biomarkers Market Size and Growth Rate of Proteomics Market, 2015 - 2026 (USD Million)

    • Figure Neurological Biomarkers Market Size and Growth Rate of Genomics Market, 2015 - 2026 (USD Million)

    • Figure Neurological Biomarkers Market Size and Growth Rate of Imaging Market, 2015 - 2026 (USD Million)

    • Figure Neurological Biomarkers Market Size and Growth Rate of Bioinformatics Market, 2015 - 2026 (USD Million)

    • Figure Neurological Biomarkers Market Size and Growth Rate of Others Market, 2015 - 2026 (USD Million)

    • Figure Neurological Biomarkers Market Size and Growth Rate of Diagnostics from 2014 to 2026

    • Figure Neurological Biomarkers Market Size and Growth Rate of Drug Discovery from 2014 to 2026

    • Figure Neurological Biomarkers Market Size and Growth Rate of Personalized Medicine from 2014 to 2026

    • Figure Neurological Biomarkers Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Germany Neurological Biomarkers Market Size and Growth Rate from 2014 to 2026

    • Figure UK Neurological Biomarkers Market Size and Growth Rate from 2014 to 2026

    • Figure France Neurological Biomarkers Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Neurological Biomarkers Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Neurological Biomarkers Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Neurological Biomarkers Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Neurological Biomarkers Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland Neurological Biomarkers Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Neurological Biomarkers Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Neurological Biomarkers Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Neurological Biomarkers Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Neurological Biomarkers Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark Neurological Biomarkers Market Size and Growth Rate from 2014 to 2026

    • Figure Finland Neurological Biomarkers Market Size and Growth Rate from 2014 to 2026

    • Figure Norway Neurological Biomarkers Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden Neurological Biomarkers Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland Neurological Biomarkers Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) Neurological Biomarkers Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Neurological Biomarkers Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands Neurological Biomarkers Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg Neurological Biomarkers Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) Neurological Biomarkers Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia Neurological Biomarkers Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia Neurological Biomarkers Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania Neurological Biomarkers Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Neurological Biomarkers Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Neurological Biomarkers

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Neurological Biomarkers by Different Types from 2014 to 2026

    • Table Consumption Share of Neurological Biomarkers by Different Types from 2014 to 2026

    • Figure Neurological Biomarkers Market Size and Growth Rate of Proteomics Market, 2015 - 2026 (USD Million)

    • Figure Neurological Biomarkers Market Size and Growth Rate of Genomics Market, 2015 - 2026 (USD Million)

    • Figure Neurological Biomarkers Market Size and Growth Rate of Imaging Market, 2015 - 2026 (USD Million)

    • Figure Neurological Biomarkers Market Size and Growth Rate of Bioinformatics Market, 2015 - 2026 (USD Million)

    • Figure Neurological Biomarkers Market Size and Growth Rate of Others Market, 2015 - 2026 (USD Million)

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Neurological Biomarkers by Different End-Users from 2014 to 2026

    • Table Consumption Share of Neurological Biomarkers by Different End-Users from 2014 to 2026

    • Figure Neurological Biomarkers Market Size and Growth Rate of Diagnostics from 2014 to 2026

    • Figure Neurological Biomarkers Market Size and Growth Rate of Drug Discovery from 2014 to 2026

    • Figure Neurological Biomarkers Market Size and Growth Rate of Personalized Medicine from 2014 to 2026

    • Figure Neurological Biomarkers Market Size and Growth Rate of Others from 2014 to 2026

    • Table Europe Neurological Biomarkers Production by Major Regions

    • Table Europe Neurological Biomarkers Production Share by Major Regions

    • Figure Europe Neurological Biomarkers Production Share by Major Countries and Regions in 2014

    • Table Europe Neurological Biomarkers Consumption by Major Regions

    • Table Europe Neurological Biomarkers Consumption Share by Major Regions

    • Table Germany Neurological Biomarkers Production, Import, Consumption and Export Analysis

    • Table UK Neurological Biomarkers Production, Import, Consumption and Export Analysis

    • Table France Neurological Biomarkers Production, Import, Consumption and Export Analysis

    • Table Italy Neurological Biomarkers Production, Import, Consumption and Export Analysis

    • Table Spain Neurological Biomarkers Production, Import, Consumption and Export Analysis

    • Table Poland Neurological Biomarkers Production, Import, Consumption and Export Analysis

    • Table Russia Neurological Biomarkers Production, Import, Consumption and Export Analysis

    • Table Switzerland Neurological Biomarkers Production, Import, Consumption and Export Analysis

    • Table Turkey Neurological Biomarkers Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Neurological Biomarkers Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Neurological Biomarkers Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) Neurological Biomarkers Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Neurological Biomarkers Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Neurological Biomarkers Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Neurological Biomarkers Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Neurological Biomarkers Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany Neurological Biomarkers Consumption by Types from 2014 to 2026

    • Table Germany Neurological Biomarkers Consumption Share by Types from 2014 to 2026

    • Table Germany Neurological Biomarkers Consumption by End-Users from 2014 to 2026

    • Table Germany Neurological Biomarkers Consumption Share by End-Users from 2014 to 2026

    • Table UK Neurological Biomarkers Consumption by Types from 2014 to 2026

    • Table UK Neurological Biomarkers Consumption Share by Types from 2014 to 2026

    • Table UK Neurological Biomarkers Consumption by End-Users from 2014 to 2026

    • Table UK Neurological Biomarkers Consumption Share by End-Users from 2014 to 2026

    • Table France Neurological Biomarkers Consumption by Types from 2014 to 2026

    • Table France Neurological Biomarkers Consumption Share by Types from 2014 to 2026

    • Table France Neurological Biomarkers Consumption by End-Users from 2014 to 2026

    • Table France Neurological Biomarkers Consumption Share by End-Users from 2014 to 2026

    • Table Italy Neurological Biomarkers Consumption by Types from 2014 to 2026

    • Table Italy Neurological Biomarkers Consumption Share by Types from 2014 to 2026

    • Table Italy Neurological Biomarkers Consumption by End-Users from 2014 to 2026

    • Table Italy Neurological Biomarkers Consumption Share by End-Users from 2014 to 2026

    • Table Spain Neurological Biomarkers Consumption by Types from 2014 to 2026

    • Table Spain Neurological Biomarkers Consumption Share by Types from 2014 to 2026

    • Table Spain Neurological Biomarkers Consumption by End-Users from 2014 to 2026

    • Table Spain Neurological Biomarkers Consumption Share by End-Users from 2014 to 2026

    • Table Poland Neurological Biomarkers Consumption by Types from 2014 to 2026

    • Table Poland Neurological Biomarkers Consumption Share by Types from 2014 to 2026

    • Table Poland Neurological Biomarkers Consumption by End-Users from 2014 to 2026

    • Table Poland Neurological Biomarkers Consumption Share by End-Users from 2014 to 2026

    • Table Russia Neurological Biomarkers Consumption by Types from 2014 to 2026

    • Table Russia Neurological Biomarkers Consumption Share by Types from 2014 to 2026

    • Table Russia Neurological Biomarkers Consumption by End-Users from 2014 to 2026

    • Table Russia Neurological Biomarkers Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland Neurological Biomarkers Consumption by Types from 2014 to 2026

    • Table Switzerland Neurological Biomarkers Consumption Share by Types from 2014 to 2026

    • Table Switzerland Neurological Biomarkers Consumption by End-Users from 2014 to 2026

    • Table Switzerland Neurological Biomarkers Consumption Share by End-Users from 2014 to 2026

    • Table Turkey Neurological Biomarkers Consumption by Types from 2014 to 2026

    • Table Turkey Neurological Biomarkers Consumption Share by Types from 2014 to 2026

    • Table Turkey Neurological Biomarkers Consumption by End-Users from 2014 to 2026

    • Table Turkey Neurological Biomarkers Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Neurological Biomarkers Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Neurological Biomarkers Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Neurological Biomarkers Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Neurological Biomarkers Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Neurological Biomarkers Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Neurological Biomarkers Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark Neurological Biomarkers Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Neurological Biomarkers Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Neurological Biomarkers Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Neurological Biomarkers Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Neurological Biomarkers Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Neurological Biomarkers Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Neurological Biomarkers Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Neurological Biomarkers Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Neurological Biomarkers Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Neurological Biomarkers Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Neurological Biomarkers Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium Neurological Biomarkers Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Neurological Biomarkers Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg Neurological Biomarkers Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Neurological Biomarkers Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Neurological Biomarkers Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Neurological Biomarkers Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Neurological Biomarkers Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Neurological Biomarkers Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Neurological Biomarkers Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia Neurological Biomarkers Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia Neurological Biomarkers Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries Neurological Biomarkers Market Volume and Growth Rate from 2014 to 2026

    • Table Merck Profiles

    • Table Merck Production, Value, Price, Gross Margin 2014-2019

    • Table Merck Product benchmarking

    • Table Merck Strategic initiatives

    • Table Merck SWOT analysis

    • Table Genewiz Profiles

    • Table Genewiz Production, Value, Price, Gross Margin 2014-2019

    • Table Genewiz Product benchmarking

    • Table Genewiz Strategic initiatives

    • Table Genewiz SWOT analysis

    • Table Proteome Sciences Profiles

    • Table Proteome Sciences Production, Value, Price, Gross Margin 2014-2019

    • Table Proteome Sciences Product benchmarking

    • Table Proteome Sciences Strategic initiatives

    • Table Proteome Sciences SWOT analysis

    • Table Cisbio Bioassays Profiles

    • Table Cisbio Bioassays Production, Value, Price, Gross Margin 2014-2019

    • Table Cisbio Bioassays Product benchmarking

    • Table Cisbio Bioassays Strategic initiatives

    • Table Cisbio Bioassays SWOT analysis

    • Table Aepodia Profiles

    • Table Aepodia Production, Value, Price, Gross Margin 2014-2019

    • Table Aepodia Product benchmarking

    • Table Aepodia Strategic initiatives

    • Table Aepodia SWOT analysis

    • Table QIAGEN Profiles

    • Table QIAGEN Production, Value, Price, Gross Margin 2014-2019

    • Table QIAGEN Product benchmarking

    • Table QIAGEN Strategic initiatives

    • Table QIAGEN SWOT analysis

    • Table Wuxi APP Profiles

    • Table Wuxi APP Production, Value, Price, Gross Margin 2014-2019

    • Table Wuxi APP Product benchmarking

    • Table Wuxi APP Strategic initiatives

    • Table Wuxi APP SWOT analysis

    • Table Athena Diagnostics Profiles

    • Table Athena Diagnostics Production, Value, Price, Gross Margin 2014-2019

    • Table Athena Diagnostics Product benchmarking

    • Table Athena Diagnostics Strategic initiatives

    • Table Athena Diagnostics SWOT analysis

    • Table Myriad RBM Profiles

    • Table Myriad RBM Production, Value, Price, Gross Margin 2014-2019

    • Table Myriad RBM Product benchmarking

    • Table Myriad RBM Strategic initiatives

    • Table Myriad RBM SWOT analysis

    • Table BGI Profiles

    • Table BGI Production, Value, Price, Gross Margin 2014-2019

    • Table BGI Product benchmarking

    • Table BGI Strategic initiatives

    • Table BGI SWOT analysis

    • Table Roche Profiles

    • Table Roche Production, Value, Price, Gross Margin 2014-2019

    • Table Roche Product benchmarking

    • Table Roche Strategic initiatives

    • Table Roche SWOT analysis

    • Table Bio-Rad Laboratories Profiles

    • Table Bio-Rad Laboratories Production, Value, Price, Gross Margin 2014-2019

    • Table Bio-Rad Laboratories Product benchmarking

    • Table Bio-Rad Laboratories Strategic initiatives

    • Table Bio-Rad Laboratories SWOT analysis

    • Table Thermo Fisher Profiles

    • Table Thermo Fisher Production, Value, Price, Gross Margin 2014-2019

    • Table Thermo Fisher Product benchmarking

    • Table Thermo Fisher Strategic initiatives

    • Table Thermo Fisher SWOT analysis

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US